BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 10968429)

  • 1. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
    Armstrong D
    Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the most effective treatment for severe gastro-oesophageal reflux disease?
    Maret-Ouda J; Brusselaers N; Lagergren J
    BMJ; 2015 Jun; 350():h3169. PubMed ID: 26108963
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
    Klinkenberg-Knol EC; Nelis F; Dent J; Snel P; Mitchell B; Prichard P; Lloyd D; Havu N; Frame MH; Romàn J; Walan A;
    Gastroenterology; 2000 Apr; 118(4):661-9. PubMed ID: 10734017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections of the esophagus and the stomach.
    Quiding-Järbrink M; Bove M; Dahlén G
    Periodontol 2000; 2009 Feb; 49():166-78. PubMed ID: 19152533
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical management of gastroesophageal reflux disease/Barrett's esophagus.
    D'Cunha J; Andrade RS; Maddaus MA
    Minerva Chir; 2011 Feb; 66(1):7-19. PubMed ID: 21389921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole in oesophageal reflux disease.
    Dawson R; Manson JM
    Lancet; 2000 Nov; 356(9243):1770-1. PubMed ID: 11095286
    [No Abstract]   [Full Text] [Related]  

  • 7. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis.
    Newton M; Burnham WR; Kamm MA
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
    Kuipers EJ; Lundell L; Klinkenberg-Knol EC; Havu N; Festen HP; Liedman B; Lamers CB; Jansen JB; Dalenback J; Snel P; Nelis GF; Meuwissen SG
    N Engl J Med; 1996 Apr; 334(16):1018-22. PubMed ID: 8598839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is long-term acid suppression dangerous in existing Helicobacter pylori infection?].
    Katsoulis S; Fölsch UR
    Z Gastroenterol; 1997 Sep; 35(9):891-4. PubMed ID: 9432821
    [No Abstract]   [Full Text] [Related]  

  • 11. Reflux and acid peptic diseases in the elderly.
    Soumekh A; Schnoll-Sussman FH; Katz PO
    Clin Geriatr Med; 2014 Feb; 30(1):29-41. PubMed ID: 24267600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors or surgery for gastro-oesophageal reflux disease.
    Hinder RA
    Dig Liver Dis; 2002 Feb; 34(2):95-6. PubMed ID: 11926565
    [No Abstract]   [Full Text] [Related]  

  • 13. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
    Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
    Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and gastric neoplasia.
    Kuipers EJ
    Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
    Thjodleifsson B; Rindi G; Fiocca R; Humphries TJ; Morocutti A; Miller N; Bardhan KD;
    Aliment Pharmacol Ther; 2003 Feb; 17(3):343-51. PubMed ID: 12562446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should Barrett's ulceration be treated?
    Peters JH; Wang KK
    Surg Endosc; 2004 Feb; 18(2):338-44. PubMed ID: 14712389
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of long-term omeprazole treatment.
    Pashankar DS
    Gastroenterology; 2000 Oct; 119(4):1177-8. PubMed ID: 11203032
    [No Abstract]   [Full Text] [Related]  

  • 19. Barrett's Esophagus, fundoplication, and cancer.
    Watson DI; Mayne GC; Hussey DJ
    World J Surg; 2007 Mar; 31(3):447-9. PubMed ID: 17334863
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
    Caos A; Breiter J; Perdomo C; Barth J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):193-202. PubMed ID: 16091056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.